Clinical trials

Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy

Determine the impact of bromocriptine on the improvement in LVEF for women presenting with PPCM.

https://inova.org/clinical-trials/randomized-evaluation-bromocriptine-myocardial-recovery-therapy-rebirth-peripartum

MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

https://inova.org/clinical-trials/magnitude-phase-3-multinational-multicenter-randomized-double-blind-placebo

A Phase II Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure (RENEU-HF)

https://inova.org/clinical-trials/phase-ii-randomized-double-blind-placebo-controlled-study-assess-safety-and

Torsemide comparison with furosemide for management of heart failure (TRANSFORM-HF)

Transform Ro 1 Advanced HF Ancillary Biomarker Study

Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy

MAGNITUDE: A Phase 3, Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of NTLA-2001 in Participants with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)

A Phase II Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure (RENEU-HF)